Cobro Ventures

About The Fund

Cobro Ventures is a private investment firm that is keenly focused on the development and nurturing of companies in several dynamic industries, specifically in the realms of Software, PropTech, BioTech, HealthTech and Fitness, Medical Devices and Hospital Services, Real Estate and Construction, and broadly in Healthcare and Wellness. Their investment strategy primarily caters to early-stage ventures, with specialties in Seed, Series A, and Series B funding stages. Cobro Ventures prides itself on its rich 20+ year history of experience, where they have been founders, operators, and investors, creating and guiding businesses towards success and eventually leading them to both private and public exits. The firm is active in providing not only venture capital but also valuable resources and specialized expertise to significantly contribute to the innovation phases crucial to a company’s growth. Cobro Ventures commits to investments with a minimum of $100,000 and a maximum of $5,000,000, with their preferred 'sweet spot' for investments being around $1,500,000. Their portfolio boasts involvement in diverse projects, including those listed on Nasdaq like CCCC working on destroying disease-causing proteins, FREQ focused on activating the body's innate healing ability, and others engaged in developing reparative E-CEL therapies, RNA-directed therapeutics, nerve function restoration, synthetic miniprotein therapeutics, and life-changing drug delivery devices. They are heavily invested in making significant impacts, supporting world-class scientific and technological experts, leveraging intellectual property expertise, and ensuring strategic business development along with high employee satisfaction.